PHARMAC documents that matched your search:
Pharmaceutical companies are being reminded of their obligation to supply medicines for patients and will be closely monitored to ensure they comply with their contracts. PHARMAC chief executive Wayne McNee says it is frustrating that companies are continuing to run out of stocks of some medicines despite PHARMAC raising concerns about the same issue in past years.
PHARMAC Pharmaceutical Management Agency New Zealand Pharmaceutical Schedule UPDATE Effective 1 February 2003 Cumulative Update for January & February 2003 Contents Summary of decisions effective 1 February 2003 ….. 3 Reference pricing of Flixotide (fluticasone) MDIs …. 4 Timolol and…
Summary of PHARMAC decisions effective 1 February 2003
(8 pages, 39 KB)
This Update to Section H contains a full list of pharmaceuticals that are now subject to national contracts. It can be used to replace Part II (pages 15 and 16) of the December 2002 edition of Section H.